Biovantix Biotechnology, Inc — Form D
Biovantix Biotechnology, Inc of DOVER, DE, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-17. The offering totals $15.0M. Industry: Biotechnology.
Offering
- Filed: 2025-10-17
- Form: D
- Accession: 0001683168-25-007628
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.0M
- Remaining: $15.0M
- Minimum investment: $10K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-561292
Issuer
- Name: Biovantix Biotechnology, Inc
- CIK: 0002092174
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 8 THE GREEN STE A, DOVER, DE, 19901
- Phone: 714-365-2391
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Christian Carnes | Executive Officer | Dover, DE |
| Jack Sunier | Executive Officer | Dover, DE |
| Elena Verutina | Executive Officer | Dover, DE |
Other filings by this issuer (1)
More